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Objective: Synthesise evidence regarding effectiveness of progressive and resisted or non-
progressive and non-resisted exercise compared with placebo or no treatment, in rotator cuff 
related pain.
Data sources: English articles, searched in Cochrane CENTRAL, MEDLINE, EMBASE and 
CINAHL databases up until May 19, 2020.
Methods: Randomised controlled trials in people with rotator cuff related pain comparing 
either progressive and resisted exercise or non-progressive and non-resisted exercise, with 
placebo or no treatment were included. Data extracted independently by two authors. Risk of 
bias appraised with the Cochrane Collaboration tool.
Results: Seven trials (468 participants) were included, four trials (271 participants) included 
progressive and resisted exercise and three trials (197 participants) included non-progressive 
or non-resisted exercise. There was uncertain clinical benefit for composite pain and function 
(15 point difference, 95% CI 9 to 21, 100 point scale) and pain outcomes at >6 weeks to 6 
months with progressive and resisted exercise compared to placebo or no treatment 
(comparison 1). For non-progressive or non-resisted exercise there was no significant benefit 
for composite pain and function (4 point difference, 95% CI -2 to 9, 100 point scale) and pain 
outcomes at >6 weeks to 6 months compared to placebo or no treatment (comparison 2). 
Adverse events were seldom reported and mild.
Conclusions: There is uncertain clinical benefit for all outcomes with progressive and 
resisted exercise and no significant benefit with non-progressive and non-resisted exercise, 
versus no treatment or placebo at >6 weeks to 6 months. Findings are low certainty and 
should be interpreted with caution.
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Objective: Synthesise evidence regarding effectiveness of progressive and resisted or non-
progressive and non-resisted exercise compared with placebo or no treatment, in rotator cuff 
related pain.
Data sources: English articles, searched in Cochrane CENTRAL, MEDLINE, EMBASE and 
CINAHL databases up until May 19, 2020.
Methods: Randomised controlled trials in people with rotator cuff related pain comparing 
either progressive and resisted exercise or non-progressive and non-resisted exercise, with 
placebo or no treatment were included. Data extracted independently by two authors. Risk of 
bias appraised with the Cochrane Collaboration tool.
Results: Seven trials (468 participants) were included, four trials (271 participants) included 
progressive and resisted exercise and three trials (197 participants) included non-progressive 
or non-resisted exercise. There was uncertain clinical benefit for composite pain and function 
(15 point difference, 95% CI 9 to 21, 100 point scale) and pain outcomes at >6 weeks to 6 
months with progressive and resisted exercise compared to placebo or no treatment 
(comparison 1). For non-progressive or non-resisted exercise there was no significant benefit 
for composite pain and function (4 point difference, 95% CI -2 to 9, 100 point scale) and pain 
outcomes at >6 weeks to 6 months compared to placebo or no treatment (comparison 2). 
Adverse events were seldom reported and mild.
Conclusions: There is uncertain clinical benefit for all outcomes with progressive and 
resisted exercise and no significant benefit with non-progressive and non-resisted exercise, 
versus no treatment or placebo at >6 weeks to 6 months. Findings are low certainty and 
should be interpreted with caution.
Key Words: Rotator cuff related pain, rotator cuff tendinopathy, sub-acromial impingement, 
resistance exercise, progressive exercise, resistance training, shoulder pain

































































1 Shoulder pain affects 15-30% of the population and is the third most common 
2 musculoskeletal condition presenting to primary care.1, 2 Rotator cuff related pain is the most 
3 common cause of shoulder pain, accounting for up to 80% of all cases.3 Up to 50% of people 
4 affected experience pain and disability beyond 12 months despite conservative treatment.3 
5 Clinical guidelines recommend clinician-guided exercise for rotator cuff related pain.4, 5 
6 However, an updated Cochrane review found only one high quality randomised controlled 
7 trial (120 participants) out of 60 (3,620 participants) that compared exercise and manual 
8 therapy for rotator cuff related shoulder pain to placebo, with no difference in clinical 
9 outcomes at 22 weeks.6, 7 Two trials (89 participants) of very low quality found similar results 
10 in comparison to no treatment.8, 9 Other systematic reviews that compare exercise with or 
11 without manual therapy to all no-exercise controls found very low quality evidence that 
12 exercise was beneficial for pain.10-12 
13
14 Resistance exercise has previously been shown to be of benefit for knee osteoarthritis,13 back 
15 pain14 and is a widely used and recommended treatment modality.15, 16 Resistance exercise 
16 includes movement against body weight, gravity or by adding load with weight or elastic 
17 resistance band (Theraband). Exercise is considered progressive and resisted when the 
18 amount of load applied is increased over time as the body adapts to the demand that it is 
19 placed under.
20
21 Prior reviews of rotator cuff related pain, including Page et al.7 have considered all exercise 
22 interventions as equal, without consideration of how the exercise was prescribed (i.e. if there 
23 was added resistance that was progressed over time or if resistance was not applied or not 
24 progressed).7, 17-22 Therefore, it remains unclear whether exercise that is resisted and 
25 progressed is more beneficial than placebo or control in treating rotator cuff realated pain. 

































































26 Likewise, it is not clear if exercise that is not resisted or not progressed is more effective than 
27 placebo or control in managing rotator cuff related pain. This remains an unanswered 
28 important clinical question in determining the most effective type of exercise intervention for 
29 rotator cuff related pain. In a previous narrative review, studies that included progressively 
30 loaded exercise and greater dose appeared to report superior outcomes compared to various 
31 interventions including no treatment, shockwave therapy and therapeutic ultrasound.23 No 
32 systematic reviews have distinguished between type of exercise for rotator cuff related pain. 
33
34 This systematic review aims to investigate the effectiveness of progressive and resisted 
35 exercise and the effectiveness of non-progressive and non-resisted exercise; compared to 
36 placebo or no treatment in the management of rotator cuff related pain.
37
38 Methods
39 The methods in this review were similar to methods in the recently updated Cochrane review 
40 of manual therapy and exercise interventions for rotator cuff related pain.7 This review was 
41 submitted May 30th 2019 to the International Prospective Register of Systematic Reviews 
42 (PROSPERO; reference CRD42019136513) and registered on August 2nd 2019.
43
44 Randomised controlled trials written in any language were included regardless of type. 
45 Participants over 16 years old with a primary complaint of rotator cuff related pain of any 
46 duration were included. Diagnostic criteria included anterolateral shoulder pain (with or 
47 without referral into the arm), preserved passive range of shoulder movement, shoulder pain 
48 with movement or resisted shoulder muscle contraction (e.g. empty/full can tests). 
49 Randomised controlled trials using synonyms for rotator cuff related pain (e.g. subacromial 
50 impingement syndrome, rotator cuff tendinopathy, rotator cuff tendinitis) were included.


































































52 Exclusion criteria included participants with a full thickness tear involving more than one 
53 rotator cuff tendon (based on clinical presentation or imaging findings, recognizing that some 
54 included participants may have undetected rotator cuff tears), gross shoulder instability, 
55 significant shoulder trauma, previous shoulder surgery, shoulder osteoarthritis, hemiplegic 
56 shoulders, a complex myofascial neck/shoulder/arm pain condition, suspected cervical spine 
57 referred pain, or a systemic inflammatory condition (e.g. rheumatoid arthritis), unless data 
58 were presented separately for our population of interest. 
59
60 In contrast to the review by Page et al. where all exercise was considered equal,7 we 
61 considered the type of exercise intervention. We included randomised trials with the 
62 following comparisons: 1) Progressive and resisted exercise versus placebo or no treatment; 
63 2) Non-progressive or non-resisted exercise versus placebo or no treatment. Trials using 
64 progressive and resisted exercise were eligible if they explicitly stated within the intervention 
65 description how resistance was applied (e.g. theraband, weight), and that there was 
66 progression of the volume or the load, or both, over time. Trials using non-progressive or 
67 non-resisted exercise were eligible if they explicitly stated that load was not applied or not 
68 progressed, or both. Non-progressive or non-resisted exercise could include active movement 
69 exercise against gravity or with gravity removed, and trials that progressed range of motion 
70 or the type of exercise (e.g. basic static to through range) were excluded if resistance within 
71 each exercise was progressed. The comparator group could include placebo interventions 
72 (e.g. detuned laser provided as an alternative to ‘physical therapy’) and no treatment. We did 
73 not exclude randomised trials that included cointerventions (e.g. manual therapy, advice) as 
74 part of the intervention or comparator group, but we planned secondary analyses to determine 
75 the effect of these interventions.


































































77 An a priori decision was made to include composite pain and function shoulder outcomes 
78 and/or pain outcomes given these are patient-important and considered a core outcome domain 
79 by shoulder experts.24 Composite pain and function based on standardised questionnaire was 
80 the primary outcome of interest. When multiple scales were reported, data were extracted 
81 according to the following hierarchy;7 1) Shoulder Pain and Disability Index (SPADI);25 2) 
82 Croft Shoulder Disability Questionnaire;26 3) Constant-Murley Score;27 4) any other shoulder-
83 specific function scale. Secondary outcomes of interest included overall pain, pain with 
84 activity, and pain at rest (measured on VAS, numerical or categorical rating scale). If overall 
85 pain was not reported, we substituted another pain measure for that analysis in the following 
86 hierarchy, unspecified, rest pain or other pain. Number of participants experiencing an adverse 
87 event (as defined by the authors) were also extracted.
88
89 All outcomes times were extracted and grouped to identify short (up to 6 weeks), medium 
90 (longer than 6 weeks and up to 6 months) and long-term (longer than 6 months) effects of the 
91 exercise interventions. The primary time range was long r than 6 weeks and up to 6 months 
92 given this is sufficient time for exercise interventions to have an effect.28 The longest time 
93 point was extracted when multiple time points were reported within the above defined 
94 periods. 
95
96 Randomised controlled trials published up to March 2015 were identified from the updated 
97 Cochrane review of manual therapy and exercise interventions for rotator cuff related pain.7 
98 The search from the Page et al7 2016 review was repeated excluding search terms for 
99 adhesive capsulitis and manual therapy given these were not relevant for our review 
100 (Appendix 1). 


































































102 The search included the following databases: Cochrane Central Register of Controlled Trials 
103 (CENTRAL; The Cochrane Library May 2020, Issue 5), Ovid MEDLINE (March 2015 to 
104 May 2020), Ovid EMBASE (March 2015 to May 2020), and CINAHL Plus (EBSCO, March 
105 2015 to May 2020). Gray literature was searched via OpenGray and ongoing trials via the 
106 National Institute of Health (clinicaltrials.gov) and the World Health Organisation 
107 (http://www.who.int/ictrp) International Clinical Trials Registries. 
108
109 Titles and abstracts were screened independently by two authors (PM, GS), and the full text 
110 was reviewed by the same author independently if required to determine eligibility. 
111 Consensus on discrepancies was reached via discussion, otherwise a third author (CL or JN) 
112 was available to assist if consensus was not reached. 
113
114 Data were extracted independently by two authors (PM, GS) to a standard data extraction 
115 form, and discrepancies were resolved via discussion, or a third author (CL) was consulted to 
116 adjudicate when required. Authors were emailed twice over four weeks to retrieve missing 
117 data. All data extraction was checked by a third author (JN). Missing SDs were calculated 
118 from standard errors (SEs), 95% CIs or P values, otherwise we planned to impute SDs from 
119 other trials in the meta-analyses (median of available SDs) if no measures of variation were 
120 reported.29 For the primary outcome of function and pain we calculated the median of 
121 available SDs in three studies following the process described above.8, 30, 31 For activity pain 
122 and rest pain we calculated SDs as above for two studies.30, 31. For Giombini et al,32 the 
123 reported measure of variability was much lower (by a factor of 4) than all other studies and 
124 we assumed it was a standard error (this could not be confirmed by the authors at the time of 
125 publication). 


































































127 The data extracted from each randomised trial are shown below: 
128  Trial characteristics (author name, year published, trial type [e.g. parallel, crossover], 
129 country, funding source, trial registration [with number]). 
130  Participant characteristics (age, gender, duration of symptoms, inclusion/exclusion 
131 criteria). 
132  Exercise intervention characteristics (exercises, sets, repetitions, frequency, duration, 
133 how exercises was loaded and progressed, co-interventions, adherence measures, 
134 advice about pain).
135  Comparator intervention characteristics (details of placebo or no treatment).
136  Outcome instrument used and timing.
137  Outcome data were extracted according to the following a priori decision rules to 
138 minimise bias: 1) preference to data that was adjusted for baseline values (e.g. 
139 ANCOVA) and intention-to-treat; 2) follow-up rather than change scores extracted 
140 where possible; 3) and data extracted for only the first period of cross-over trials.
141
142 The Cochrane Collaboration’s tool was used to assess risk of bias.33 The results of the risk of 
143 bias assessment for all included trials were extracted from Page et al7 as no new studies were 
144 identified in our updated search.
145
146 Dichotomous (relative risk [RR] and 95% confidence intervals [CI]) and continuous 
147 measures (mean difference [MD] and 95% CI) of treatment effect were calculated using 
148 Review Manager 5.3 (RevMan). For continuous outcomes, MD was used after scores for the 
149 Shoulder Rating Questionnaire (17-100) and the Neer Shoulder Score (10-100) were 
150 transformed to a 0-100 scale (0 is best).34 We reversed the direction of the Constant-Murley, 

































































151 Neer and Shoulder Rating Questionnaire scores so that zero was best in all scales (to match 
152 the SPADI, the highest outcome in our hierarchy).34 Minimal clinically important difference 
153 was assumed to be 10 on a 100-point scale for composite pain and function outcome,35-37 and 
154 15 points on a 100-point scale for pain outcome.38 
155
156 Data were pooled in meta-analyses using Review Manager 5.339 if participants, interventions 
157 and outcome measures were similar. A random effects models was chosen a priori given 
158 heterogeneity is likely. Where data could not be pooled, we summarized findings 
159 descriptively and reported effect estimates and 95% confidence intervals. 
160
161 Assessment of statistical heterogeneity was based on Chi-square statistic and the I2 statistic.40 
162 For the I2 statistic, we interpreted statistical heterogeneity as not important (<50%), moderate 
163 (50-75%) and high (>75%).40 
164
165 A sensitivity analysis was planned to investigate the influence of high risk of bias studies on 
166 treatment outcomes. Subgroup analysis was planned a priori to investigate 1) the effect of 
167 exercise interventions alone versus exercise interventions including co-interventions, and 2) 
168 the effects of exercise setting (e.g. clinician-supervised or home exercise).
169
170 We prepared summary of findings tables for both comparisons and graded the certainty of 
171 evidence using a GRADE approach [Grades of Recommendation, Assessment, Development 
172 and Evaluation Working Group])41. Level of evidence was downgraded (to moderate, low or 
173 very low) for each of the following: risk of bias, inconsistency of results, indirectness, 
174 imprecision, and publication bias.
175

































































176 For dichotomous outcomes (e.g. adverse events), absolute risk difference was expressed as a 
177 percentage and relative percent change was the risk ratio – 1 expressed as a percentage. The 
178 NNTH was calculated using the event rate in the control group and risk ratio.42 For 
179 continuous outcomes (e.g. composite pain and function), absolute risk difference was the 
180 mean difference in outcome between the intervention and comparator group expressed as a 
181 percentage. The relative percent change was the mean intervention group difference (absolute 




186 Nine eligible trials were identified from the Page et al7 2016 systematic review. One trial was 
187 excluded because the control group received a standard exercise instruction pamphlet in 
188 addition to education and therefore is not a true comparison to no treatment or placebo.9 The 
189 other excluded trial included physiotherapy treatments as control (heat packs, transcutaneous 
190 electrical nerve stimulation and ultrasound).43  No eligible trials were identified after the 
191 updated search (Figure 1), and screening reference lists of included studies, gray literature 
192 and clinical trials registries. We obtained data from the authors (July 2017) of two trials6, 31 
193 that allowed us to confirm eligibility (Appendix 2). We acknowledge that within the trial 
194 protocol for the randomised trial by Bennell et al.44 there was progression of exercise through 
195 range (e.g. external rotation in side lying, to standing in neutral, to elbow supported at 90 
196 abduction, to unsupported elbow at 45 abduction). However, there was not progression of 
197 load or volume as specified in our eligibility criteria.
198
199 Figure 1: Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2009 
200 flow diagram for literature search results.



































































203 Trial and participant characteristics are shown in Table 1. Seven parallel group randomised 
204 trials (468 participants) were included. Multiple diagnostic labels were used for rotator cuff 
205 related pain but there was overlapping and consistent diagnostic criteria between trials (Table 
206 1). Mean age was between 47 and 61 years, but lower in Giombini et al32 (26 and 29 years). 
207 Men were more prevalent (54-100%) aside from Lombardi et al45 (24% men). Baseline 
208 composite pain and function was comparable (33 to 50, 0-100 point scale where 0 is best).
209
210 Description of the interventions and comparators are shown in Table 2. Three trials compared 
211 progressive and resisted exercise with no treatment.8, 45, 46 One trial compared progressive and 
212 resisted exercise with placebo (detuned laser).30 All progressive and resisted exercise 
213 interventions included scapular and rotator cuff strengthening and progressed the load 
214 (intensity) with theraband or weights.8, 30, 45, 46 Prescribed sets and repetitions varied, and only 
215 one study specified exercise intensity (50%-70% of the 6RM).45 Three studies included co-
216 interventions. Brox et al30 included education about pathology, pain and ergonomics, Dickens 
217 et al8 included manual therapy, postural advice, taping with or without electrotherapy and 
218 Ludwig et al46 included shoulder stretching. 
219
220 All three trials (four comparisons) of the non-progressive and non-resisted interventions were 
221 compared with placebo (two ultrasound6, 32 and one brace31). One non-progressive and non-
222 resisted exercise trial6 targeted scapular and rotator cuff strengthening similar to progressive 
223 and resisted trials. Whereas, Walther et al31 assessed static exercise and neck stretching (all 
224 other trials evaluate dynamic exercise) and Giombini et al32 assessed pendular exercise and 
225 shoulder stretching. Load was applied without progression with theraband or 1kg weight in 

































































226 two trials6, 31 and no load applied in the remaining trial.32 There were only co-interventions in 
227 Bennell et al6 including manual therapy and behavioural strategies (e.g. goal setting, positive 
228 reinforcement). 
229
230 Table 1: Recruitment and retention, participant characteristics and eligibility criteria
231 Table 2: Exercise characteristics and outcome 
232
233 Risk of bias in included trials
234 Risk of bias assessment was extracted from Page et al7 (summarised in Figure 2) as all our 
235 studies were also in this Cochrane review from 2016. Among trials comparing progressive 
236 and resisted exercise or non-progressive and non resisted exercise to placebo or no treatment, 
237 six (86%) were rated high risk of performance and detection bias.8, 30-32, 45, 46 Further, two 
238 trials (29%) were at high risk of reporting bias31, 32 (uncertain risk in a further four [57%]),8, 
239 30, 45, 46 one trial (14%) was at high risk of attrition bias,30 and there was uncertain risk of 
240 selection bias in five (71%) trials.8, 30-32, 46 
241
242 Figure 2: Risk of bias summary: judgements about each risk of bias item for each 
243 included study.
244
245 Effects of interventions
246 Comparison 1: Progressive and resisted exercise versus placebo or no treatment
247 There were four trials with 271 participants that reported composite pain and function,8, 30, 45, 
248 46 three trials30, 45, 46 (197 participants) reported overall pain and two trials30, 45 (135 
249 participants) reported activity pain and rest pain at >6 weeks to 6 months. No trials reported 
250 adverse events. All outcomes were downgraded twice (low certainty) for risk of bias 

































































251 (performance, detection, reporting and selection).8, 30, 46 
252
253 There was uncertain clinical benefit (low certainty evidence) in all outcomes with progressive 
254 and resisted exercise. For composite pain and function there was a 15.0 point difference (95% 
255 CI 8.6 to 21.4; 4 trials, 271 participants, Figure 3, Table 3).8, 30, 45, 46 For overall pain there 
256 was a 10.7 point difference (95% CI 5.6 to 15.7; 3 trials, 197 participants, Figure 3, Table 
257 3).30, 45, 46 For pain with activity there was a 24.7 point difference (95% CI 13.9 to 35.5; 2 
258 trials, 135 participants, Figure 3, Table 3).30, 45 For pain at rest there was a 22.8 point 
259 difference (95% CI 14.0 to 31.6; 2 trials, 135 participants, Figure 3, Table 3).30, 45
260
261 Adverse events
262 Unclear as no trials of progressive and resisted exercise reported whether adverse events 
263 occurred.
264
265 Comparison 2: Non-progressive or non-resisted exercise versus placebo and no 
266 treatment
267 Three trials (197 participants) reported composite pain and function, overall pain and pain 
268 with activity at >6 weeks to 6 months.6, 31, 32 Two trials (174 participants) reported pain at rest 
269 at >6 weeks to 6 months.6, 31 Two trials (83 participants) reported composite pain and 
270 function up to 6 weeks. One trial reported adverse events.6 Overall evidence was low 
271 certainty for all outcomes (downgraded twice for risk of bias [performance, detection, 
272 reporting and selection]).
273  
274 There was low certainty evidence of no benefit in all outcomes with non-progressive or non-
275 resisted exercise. For function there was a 3.6 point difference (95% CI -2.2 to 9.4; 3 trials, 4 

































































276 comparisons, 197 participants, Figure 4, Table 4).6, 31, 32 For overall pain there was a 3.3 point 
277 difference (95% CI -1.5 to 8.1; 3 trials, 4 comparisons, 197 participants, Figure 4, Table 4).6, 
278 31, 32 For pain with activity there was a 3.4 point difference (95% CI -5.0 to 11.8; 3 trials, 4 
279 comparisons, 197 participants, Figure 4, Table 4). 6, 31, 32 For pain at rest there was a 1.8 point 




284 One trial reported a short term increase in pain that was greater following exercise 
285 intervention (17/55) compared with placebo (5/61) (RR 4.02, 95% CI 1.56 to 10.37).6
286
287 Secondary analysis
288 Subgroup analsysis for co-interventions were similar to the overall effect for all outcomes 
289 (composite pain and function, overall pain, activity pain and rest pain) in both comparisons. 
290 One exception was composite pain and function in comparison 1, where there was benefit of 
291 uncertain clinical importance among the two trials that did not include co-interventions25,26 
292 and clinically important improvement for the two trials8, 30 that did. When subgrouping for 
293 supervised versus unsupervised exercise, comparison 1 pain and function outcome showed 
294 clinically important benefit in three trials10,28,42 that utilised supervised exercise but uncertain 
295 clinical benefit in one trial46 that utilised unsupervised exercise. All other findings were 
296 identical to the overall effect for all outcomes (composite pain and function and overall pain). 
297 There was insufficient data to perform other planned secondary analyses.
298
299 Discussion

































































300 This review identified seven randomised trials (eight comparisons, 468 participants) that 
301 compared exercise (progressive and resisted or not) to placebo or no treatment among people 
302 with rotator cuff related shoulder pain. Four trials8, 30, 45, 46 compared progressive and resisted 
303 exercise to no treatment or placebo (comparison 1) and three trials6, 31, 32 compared non-
304 progressive or non-resisted exercise to placebo (comparison 2). For progressive and resisted 
305 exercise, low certainty evidence indicates benefit of uncertain clinical importantance in 
306 composite pain and function, overall pain outcomes, pain with activity and pain at rest at >6 
307 weeks to 6 months compared to placebo or no treatment. For non-progressive or non-resisted 
308 exercise, low certainty evidence indicates no benefit for composite pain and function, overall 
309 pain, pain with activity and pain at rest at >6 weeks to 6 months compared to placebo or no 
310 treatment (comparison 2). Adverse events were reported in only one study and included only 
311 mild differences in short term pain after exercise. The trials were heterogenous (e.g. whether 
312 exercise was supervised, co-interventions used, comparators) so these findings should be 
313 viewed as preliminary and hypothesis generating.
314
315 Three (75%)8, 30, 45 of the progressive and resisted trials but only one (25%)31 of the non-
316 progressive and non-resisted trials utilised supervised exercise interventions. Three out of 
317 four (75%) progressive and resisted interventions included co-interventions in the exercise 
318 arm (e.g. manual therapy, advice) whereas only one non-progressive and non-resisted 
319 intervention (25%) utilized co-interventions. Further, three trials (75%)8, 45, 46 comparing 
320 progressive and resisted exercise were compared to no treatment, whereas all non-progressive 
321 or non-resisted exercise trials were compared with placebo. Therefore, we can only conclude 
322 that progressive and resisted studies, most of which are supervised, may offer benefit of 
323 uncertain clinical importance compared with primarily no treatment comparators. 
324


































































326 All progressive and resisted exercise programs increased load (intensity), only two 
327 progressed range of motion, volume or speed. Load progression was based on either 
328 achieving a pain response within defined limits (e.g. pain of no more than 4/10 on a 0-10 
329 scale) or based on ability (e.g. when the prescribed sets were no longer achieving muscle 
330 fatigue). There were important differences in the exercise approaches between the 
331 progressive and resisted and non-progressive and non-resisted trials that may have influenced 
332 our findings. Two trials that utilized non-progressive and non-resisted exercise prescribed 
333 either pendular exercises or isometric (static hold) exercises.31, 32 This is in contrast to the 
334 dynamic scapular and rotator cuff exercises prescribed in the progressive and resisted trials.
335
336 It is possible that mechanisms other than the exercise undertaken explain the findings. For 
337 example, giving a patient permission to perform progressive exercise, or do more exercise, 
338 may reduce fear of movement and lead to greater general shoulder use in some patients. 
339 Adherence and exercise dose parameters were also poorly reported, so we are unable to 
340 determine the dose response and actual volume of exercise completed for each intervention. 
341 We urge caution in interpreting these findings given the certainty of evidence supporting the 
342 findings are generally low using a GRADE approach. 
343
344 There have been multiple systematic reviews of exercise interventions for rotator cuff related 
345 pain.7, 10-12, 47 A recent Cochrane review concluded no benefit of exercise over placebo for 
346 rotator cuff related pain,7 which contrasts with other systematic reviews.10, 12 The difference 
347 is the Cochrane review was based on a single (judged by the authors of this review) low risk 
348 of bias study. Our findings are broadly consistent with this Cochrane review as most studies 
349 using a placebo comparison did not find benefit for exercise (albeit 75% utilized non-

































































350 progressive and non-resisted exercise). Future high quality studies investigating whether 
351 progressive and resisted exercise is more beneficial than placebo are warranted. 
352
353 This is the first systematic review with meta-analysis to focus on progressive and resisted 
354 exercise or not versus no treatment or placebo. Further, in this review we followed as closely 
355 as possible best practice guidelines as outlined by the Cochrane collaboration and PRISMA 
356 to minimize potential sources of bias in this review. Inclusion and exclusion criteria were 
357 carefully decided a priori and were clearly defined to minimize selection bias. 
358
359 The main limitation of our review is that there were only 7 trials and 8 comparisons that met 
360 our inclusion and exclusion criteria. Potential bias and the limited number of trials identified 
361 reduced confidence in our findings, however the findings are consistent with evidence in 
362 other tendinopathies around the body and worthy of further investigation.48
363
364 There are several limitations of the literature we included. There is low certainty evidence for 
365 both comparison one and two, only one trial6 in this review has a low risk of bias (86% had a 
366 high risk of bias, therefore certainty was downgraded two levels, we did not downgrade for 
367 inconsistency, indrectness [all interventions reflected clinical practice] or imprecision). This 
368 precluded sensitivity analysis including only low risk of bias trials. Further, as discussed, 
369 there were more progressive and resisted trials that utilized supervised exercise and co-
370 interventions, and used non-placebo controls, so these factors may have influenced the 
371 positive findings reported for this exercise type.
372
373 Exercise programs were not described fully. This included characteristics such as pain during 
374 loading, exercise adherence, rest between exercise sets and exercise tempo. This limitation is 

































































375 important because exercise dose may contribute to the positive findings and clinicians are 
376 unable to implement an exercise program if exercise characteristics are incompletely 
377 reported. Limited reporting on exercise programs may also have influenced our decision to 
378 classify studies as progressive and resisted or non-progressive and non-resisted. Future trials 
379 should consider reporting guidelines (e.g. Consensus on Exercise Reporting Template)49 to 
380 ensure findings are translatable to practice. 
381
382 Implications for practice
383 Progressive resistance exercise may improve function and pain outcomes in rotator cuff 
384 related cuff related pain in comparison to placebo or no treatment comparators. The benefit 
385 was of uncertain clinical importance and placebo effects were not controlled in 75% of 
386 studies. Three quarters of progressive and resisted exercise interventions were supervised and 
387 included co-interventions such as manual therapy or advice or shoulder stretching. Clinicians 
388 can consider adopting similar progressive and resisted exercise interventions for rotator cuff 
389 related pain but the low certainty findings in this review indicate that our findings may 
390 change in the future (if there are larger and adequately powered studies addressing the same 
391 question). Non-progressive and non-resisted exercise did not demonstrate benefit over 
392 primary (75%) placebo comparisons. Our results question the use of non-resisted or non-
393 progressive exercise for rotator cuff related pain. 
394 Future high quality, adequately powered randomised trials should consider the type of 
395 exercise prescribed for the intervention, specifically how resistance is added and if it is 
396 progressed appropriately throughout the treatment (increasing the intensity of the resistance 
397 and also increasing the range at which the exercise is performed).


































































399  Progressive and resisted exercise may provide uncertain clinical benefit in pain and 
400 function compared with primarily no treatment comparators at >6 weeks to 6 months 
401 among people with rotator cuff related pain
402  Non-progressive and non-resisted exercise did not demonstrate benefit over placebo 
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randomised total, per 
group, number 
available at follow-up















Progressive and resisted exercise versus placebo or no treatment
Brox et al. 
1993, rotator 
cuff disease
195 screened, 125 
randomised, 30 
placebo laser, 50 
supervised exercises, 
45 arthroscopic 
surgery not included in 
this review, follow up 
79
Supervised exercise group: 
47 years, 44% men, 66 (10-100, 100 best), 
overall pain 15 (0-100, 0 best), 24 months
Placebo Laser group: 
48 years, 50% men, 65 (10-100, 100 best), 










Yes (LA) Restricted passive range of 
motion, arthritis 
acromioclavicular joint, cervical 
syndrome, rotator cuff rupture, 
glenohumeral instability, bilateral 
pain and tenderness/decreased 
ability to relax shoulder, neck and 
temporomandibular joints





Number screened not 
reported, 85 




exercises, follow up 73
No treatment group: 
54 years, 55% men, 56 (0-100, 100 best), 
overall pain not reported, duration of 
symptoms not reported
Non-progressive physiotherapy exercise 
group:
55 years, 58% men, 52 (0-100, 100 best), 
















Cervical radiculopathy, adhesive 
capsulitis, ‘clinically obvious’ 
rotator cuff tear, grade III 







Number screened not 
reported, 60 
randomised, 30 no 
treatment 
(physiotherapy waiting 




55 years, 17% men, 47 (0-100, 0 best), 
overall pain 44 (0-100, 100 best), 14 
months
Progressive resistance exercise group:
56 years, 30% men, 50 (0-100, 0 best), 

















Shoulder fractures or dislocation 
history; cervical radiculopathy; 
degenerative glenohumeral joint 
disease;
shoulder, back, or thorax surgery; 
inflammatory arthropathy; 
shoulder injection in previous 3 
months; people undergoing any 
physical interventions for the 
shoulder





110 screened, 92 





not included in this 
review, follow up 62
No treatment group: 
49 years, 100% male, 73 (17-100, 100 
best), overall pain 5 (0-10, 0 best), duration 
of symptoms not reported
Progressive resistance exercise group: 
48 years, 100% male, 66 (17-100, 100 
best), overall pain 5 (0-10, 0 best), duration 



















Less than 130 degrees shoulder 
elevation; cervical spine or 
periscapular pain; shoulder 
symptoms reproduced by cervical 
spine assessment; previous rotator 
cuff surgery or glenohumeral 
dislocation or other traumatic 
injury



































































biceps or rotator 
cuff tendons
Non-progressive or non-resisted exercise versus placebo or no treatment
Bennell et al. 
2010, rotator 
cuff disease
438 screened, 120 
randomised, 59 active 
intervention non-
progressive exercise 
group, 61 placebo 
sham ultrasound 
group, follow up 114
Active intervention non-progressive 
exercise group: 
59 years, 58% men, 43 (0-100, 0 best), 
overall pain 48 (0-100, 0 best), 24 months
Placebo sham ultrasound group:
61 years, 49% men, 44 (0-100, 0 best),  














Shoulder pain severity >7/10 at 
rest, suspected complete rotator 
cuff tear (+ve drop arm test, 
substantial shoulder weakness, 
high riding humeral head on 
xray), prior surgery or fracture, 
inflammatory arthritis, 
osteoarthritis or calcification on 
xray, neoplastic disorder, >50% 
reduction range of motion in 2 or 
more planes, pain referred from 
vertebral structures, complex 
regional pain syndrome, active 
interventions last 3 months (e.g. 
injection, physiotherapy), anti-










14 hyperthermia group 
not included in this 
review, follow up 23
Ultrasound control group: 
29 years, 67% men, 59 (0-100, 100 best), 
overall pain 6.3 (0-10, 0 best), 5 months 
(mean both groups)
Non-progressive exercise group: 
26 years, 82% male, 59 (0-100, 100 best), 








in 90 degrees 
forward flexion 










Restricted passive range of 
motion, traumatic onset, severe 
neck pain, frozen shoulder, 
calcific tendinopathy, 
degenerative joint disease of the 
acromioclavicular or 
glenohumeral joint; prior intra-
articular or subacromial injection 
of corticosteroids; clinical or 
ultrasonographic diagnosis of a 
rotator cuff tear; previous 
shoulder surgery on the affected 
or contralateral shoulder















group, follow up 
Functional brace (placebo) group: 
49 years, 70% men, 63 (0-100, 100 best), 
overall pain 50 (0-100, 0 best), 27 months
Self training non-progressive exercise 
group: 
52 years, 45% male, 58 (0-100, 100 best), 
overall pain 47 (0-100, 0 best), 23 months
Physio non-progressive exercise 
grouping: 
52 years, 55% male, 60 (0-100. 100 best), 












Yes (LA) Cervical radiculopathy, frozen 
shoulder, full-thickness tear of the 
rotator cuff, acromioclavicular 




disorders, pending workers’ 
compensation claim
























































































Sets x repetitions or 
time, frequency, 
duration, total 
sessions, time under 











Adherence Outcomes, extracted outcomes
Progressive and resisted exercise versus placebo or no treatment






























?, daily for one hour, 













Outcomes: Composite pain and function with 
Neer shoulder score (10-100, 100 is best), 
activity, rest and night pain with NRS (1-9, 9 
worst possible pain)
Outcomes extracted: composite pain and 
function, overall pain, activity pain, rest pain
Note: Overall pain assumed from Neer pain 
item. We reversed the direction of the function 
score and converted to a 0-100 scale for 
consistency with other studies. We estimated 
SD as a median of the available SDs






















and rotator cuff 
muscles 
Supervised 1-




Sets/reps not specified, 
twice daily, 26 weeks, 
?, ?, ?,  incalculable
Isometric, then inner 
range, through range, 
outer range, functional 
positions. 
















Outcomes: Composite pain and function with 
Constant score (0-100, 100 is best)
Outcomes extracted: composite pain and 
function
Note: We reversed the direction of the function 
score for consistency with other studies. We 
estimated SD as a median of the available SDs










medial and lateral 
rotation
Supervised, 4 
sessions in 8 
weeks 
(fortnightly)
2x8 (50% [1st set] to 
70% [2nd set] of 6 
repetition maximum 
load), twice weekly, 8 











Outcomes: Composite pain and function with 
disability of arm and shoulder score (laborious 
function component and activities of daily 
living component)                                                                                                                                                                                                                                                                              
(0-100, 0 better), quality of life short form SF-
36, activity and rest pain with VAS (0-10, 10 
worse pain)
Outcomes extracted: composite pain and 
function (laborious function), overall, activity 
and rest pain

































































Note: Overall pain assumed from the SF-36 
pain item. We reversed the direction of the SF-
36 pain score for consistency with other 
studies.
Ludwig et al. 
2003, RCT, 




service and the 
University of 
Iowa, no trial 
registration





external rotation in 




Home, 1 in 
person and 1 





Initial, at 1 
week, 
phone/option
al at 4 weeks
Stretches 30secx5/day 
& active movement 
5x/day, progressive 
exercise 3x10 – 20 (by 
3rd week), 3x/week, 10 























Outcomes: Composite pain and function with 
shoulder rating questionnaire (17-100, 100 is 
better), work related shoulder pain, work 
related disability
Outcomes extracted: composite pain and 
function, overall pain
Note: Overall pain assumed from work related 
pain item. We reversed the direction of the 
function score and converted to a 0-100 scale 
for consistency with other studies. SE reported 
and used to calculate SD.
Non-progressive or non-resisted exercise versus placebo or no treatment














































(2x10 repetitions or 5 
sec x 5 or 1-3 minute 
hold), twice daily for 
first week, daily after 















70% at 22 
weeks)
Outcomes reported: Composite pain and 
function, and overall pain with SPADI (both 0-
100, 0 is best), activity and rest pain with NRS 
(0-10, 10 worse), quality of life using SF-36
Outcomes extracted: composite pain and 
function, overall, activity and rest pain 










and extension in 






Sets/reps not specified 
(5 minutes), twice 








Outcomes reported: Composite pain and 
function with Constant-Murley score (0-100, 
100 is best), mean pain using a 10cm VAS, 
pain on resisted movement (4 point scale, 0 is 
best), 
Pain on active abduction 40-120 (4 point scale, 
0 is best)
Outcomes extracted: composite pain and 
function, overall pain, pain during movement

































































Note: Overall pain assumed from mean pain. 
Reversed the direction of the function score for 
consistency with other studies.
Walther et al. 
2004, RCT, 
Germany, ?, no 
trial 
registration 






rowing with elbow 




















pendular 3-5 mins, 
adduction & distraction 
3x15sec, group a 
5x/wk; group b 2-
3x/week, 12 weeks, ?, 
?, incalculable 










Outcomes reported; Composite pain and 
function and with Constant-Murley (0-100, 
100 is best), activity, night and rest pain (0-
100, 100 maximum pain)
Outcomes extracted: composite pain and 
function, overall pain, activity and rest pain 
Note: Overall pain assumed from night pain. 
We reversed the direction of the function score 
for consistency with other studies. We 
estimated SD as a median of the available SDs.
Note: ?=data missing; rep=repetitions, repetitions/week is the average over intervention period if weekly repetitions vary

































































Table 3. Summary of Findings: Progressive and resisted exercise compared to placebo for rotator cuff related pain
Patient or population: rotator cuff related pain 
Setting: Primary care patients (Norway), patients on surgery waiting list (UK), physiotherapy waiting list University hospital (Brazil), construction workers (USA)
Intervention: 8-26 weeks of progressive resisted exercise 
Comparison: placebo (detuned laser) or no treatment 
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI) 
№ of participants 
(studies) 
Certainty of the evidence
(GRADE) 
Comments
Assumed risk Corresponding risk
Placebo Progressive and resisted exercise
Function
Assessed with Constant-Murley (0-100, 100 is 
best), Neer (10-100, 100 is best) or SRQ (17-100, 
100 is best) or the DASH (0-100, 0 is best)
Follow-up: 8 to 26 weeks
The mean function in the 
control group was 44.21
The mean function in the 
intervention group was 15.0 points 





Statistically significant but uncertain clinical benefit2 
Absolute change 15% better (9% better to 21% better); 
relative change 32% better (18% better to 45% better)4
Overall pain
Assessed with SF36 (0-100, 0 is best), Neer (10-
100, 0 is best) or VAS (0-100, 0 is best) 
Follow-up: 8 to 26 weeks
The mean overall pain in 
the control group was 53.31
The mean overall pain in the 
intervention group was 10.7 points 





Statistically significant but uncertain clinical benefit2
Absolute change 11% better (6% better to 16% better); 
relative change 19% better (10% better to 28% better)4
Pain with activity
Assessed with VAS (0-100; 0 is best) 
Follow-up: 8 to 26 weeks
The mean pain with 
activity in the control 
group was 71.01
The mean pain with activity in the 
intervention group was 24.7 points 





Statistically significant but uncertain clinical benefit2
Absolute change 25% better (14% better to 36% 
better); relative change 35% better (20% better to 50% 
better)4
Pain at rest
Assessed with VAS (0-100; 0 is best) 
Follow-up: 8 to 26 weeks
The mean pain at rest in the 
control group was 43.01
The mean overall pain in the 
intervention group was 22.8 points 





Statistically significant but uncertain clinical benefit2
Absolute change 23% better (14% better to 32% 
better); relative change 58% better (36% better to 81% 
better)4
Adverse events - - - - - -
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect 
of the intervention (and its 95%CI). 
CI: Confidence interval; SRQ: shoulder rating questionnaire; DASH: disability of the arm, shoulder and hand; VAS: visual analogue scale; NRS: numerical rating scale
GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect 
This table summarises data from the Brox 1993, Dickens 2005, Lombardi 2008, Ludwig 2003 trials. 
1Lombardi was used as the control group risk
2We assumed a clinically important improvement in function of 10 points on a 100-point scale (or 10%) and a clinically important improvement in pain of 15 points on a 100-point scale (or 15%)
3Downgraded (-2) for risk of bias. Participants and outcome assessors were not blinded (risk of performance, detection and selection bias). Not all measured outcomes were reported
4Relative changes calculated as absolute change divided by mean at baseline in the control group from Lombardi: Mean SD values were 47.4 (24.7) for function on a 0-100 point DASH scale; 56.1 (19.2) for overall pain on 0-100 point SF36 
scale; 7.1 (1.5) for activity pain on 0-10 point VAS; 3.9 (2.6) for rest pain on 0-10 point VAS

































































Table 4. Summary of Findings: Non-progressive and non-resisted exercise compared to placebo for rotator cuff related pain
Patient or population: rotator cuff related pain
Setting: Primary care patients (Australia), University hospital (Germany) and athletes in University setting (Italy)
Intervention: 4 to 12 weeks of non-progressive and non-resisted exercise
Comparison: placebo (detuned laser, ultrasound, brace)
Illustrative comparative risks* (95% CI) 
Assumed risk Corresponding risk
Outcomes
Placebo Non-progressive and non-resisted exercise
Relative effect
(95% CI) 
№ of participants 
(studies) 





Assessed with the Constant-Murley (0 to 
100, 100 is best) or SPADI total score scales 
(0 to 100, 0 is best)
Follow-up: 10 to 22 weeks
The mean function in the 
control group was 28.31
The mean function in the intervention group 






Absolute risk difference 4% better (2% worse to 
9% better); relative change 8% better (5% 
worse to 21% better)4
Overall pain
Assessed with the SPADI pain (0-100, 0 is 
best), mean pain VAS (0-100, 0 is best), 
night pain (0-100, 0 is best)
Follow-up: 10 to 22 weeks 
The mean overall pain in the 
control group was 311
The mean overall pain in the intervention 






No significant benefit 3
Absolute risk difference 3% better (1% worse to 
8% better); relative change 7% better (3% 
worse to 17% better)4
Pain with activity
Assessed with VAS (0-100, 0 is best) or 
NRS (0-100, 0 is best) 
Follow-up: 10 to 22 weeks
The mean pain with activity in 
the control group was 331
The mean pain with activity in the intervention 
group was 3.4 points better




LOW 2  
No significant benefit3
Absolute risk difference 3% better (5% worse to 
12% better); relative change 7% better (10% 
worse to 24% better)4
Pain at rest
Assessed with VAS (0-100, 0 is best) or 
NRS (0-100, 0 is best)
Follow-up: 12 to 22 weeks
The mean pain at rest in the 
control group was 161
The mean pain at rest in the intervention group 







Absolute risk difference 0.2% better (0.7% 
worse to 1% better); relative change 9% better 




82 per 1000 309 per 1000
(122 to 782)






Absolute risk difference 23% (9% to 37% 
more); relative percentage change 277% (49% 
to 854% more) NNTH 5 (26 to 2). Adverse 
events were mild and included short-term pain 
after exercises
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect 
of the intervention (and its 95%CI). 
CI: Confidence interval; VAS: visual analogue scale; NRS: numerical rating scale; RR: Relative Risk; SPADI: Shoulder Pain and Disabilty Index
GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect 
This table summarises data from the Bennell 2010, Walther 2004 and Giombini 2006 trials. 
1Placebo group score in Bennell 2010 was used as assumed control group risk
2Downgraded (-2) for risk of bias. Participants and outcome assessors not blinded (risk of performance, detection and selection bias). Not all measured outcomes were reported in two studies with the lowest weighting
3We assumed a clinically important improvement in function of 10 points on a 100-point scale (or 10%) and a clinically important improvement in pain of 15 points on a 100-point scale (or 15%)
4Relative changes calculated as absolute change divided by mean at baseline in the control group from Bennell: Mean SD values were 43.9 (17.5) for function on a 0-100 point SPADI scale; 48.4 (17.5) for overall pain 0-100 point scale SPADI 
pain; 49 (18) for activity pain on 0-100 VAS, 21 (18) for rest pain on 0-100 point VAS
































































From:  Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta-
Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097
For more information, visit www.prisma-statement.org.
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Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2009 flow 
diagram for literature search results. 
Records identified through 





















n Additional records 
identified through other 
sources (n = 1)























Studies included from 
updated search (n = 0)
Records identified via the 
Page et al. 2016 systemic 
review (n = 9)
Studies included from 
updated search and Page 
et al. 2016 (n = 7)
Full-text articles 
excluded










































































Figure 2. Risk of bias summary: judgements about each risk of bias item for each included 
study (from Page et al).

































































Figure 3. Comparison One - Effects of progressive and resisted exercise versus placebo or no treatment on 
composite pain and function, overall pain, activity pain and rest pain





































































Figure 4. Comparison Two - Effects of non-progressive or non-resisted exercise versus placebo or no treatment 
on composite pain and function, overall pain, activity pain and rest pain







































































594 Search strategy for CENTRAL: 
595 1. MeSH descriptor: [Shoulder Pain] explode all trees 
596 2. MeSH descriptor: [Shoulder Impingement Syndrome] explode all trees 
597 3. MeSH descriptor: [Rotator Cuff] explode all trees 
598 4. MeSH descriptor: [Bursitis] explode all trees 
599 5. ((shoulder* in AllText or rotator* in AllText) and (bursitis in AllText or impinge* in 
600 AllText or tendonitis in All Text or tendonitis in All Text or tendinopathy in AllText or 
601 pain* in All Text)) 
602 6. “rotator cuff” in AllText 
603 7. #1 or #2 or #3 or #4 or #5 or #6 
604 8. MeSH descriptor: [Rehabilitation] explode all trees 
605 9. MeSH descriptor: [Physical Therapy Modalities] explode all trees 
606 10. MeSH descriptor: [Exercise Movement Techniques] explode all trees 
607 11. MeSH descriptor: [Ultrasonography, Interventional] explode all trees 
608 12. rehabilitat* in All Text or physiotherapy* in AllText or “physical therap*” in AllText 
609 or “manual therap*” in All Text or exercis* in All Text 
610 13. (ultrasound in All Text or ultrasonograph* in All Text or tns in AllText or tens in All 
611 Text or shockwave in All Text or electrotherap*in All Text or mobili* in AllText) 
612 14. #9 or #10 or #11 or #12 or #13
613 15. #8 and #15  
614 Search strategy for MEDLINE (Ovid): 
615 1. shoulder pain/ 
616 2. shoulder impingement syndrome/ 
617 3. rotator cuff/ 
618 4. exp bursitis/ 
619 5. ((shoulder$ or rotator cuff) adj5 (bursitis or impinge$ or tendinitis or tendonitis or 
620 tendinopathy or pain$)).mp. 
621 6. rotator cuff.mp. 
622 7. or/1-7
623 8. exp rehabilitation/ 
624 9. exp physical therapy techniques/ 
625 10. exp musculoskeletal manipulations/ 
626 11. exp exercise movement techniques/ 
627 12. exp ultrasonography, interventional/ 
628 13. (rehabilitat$ or physiotherap$ or physical therap$ or manual therap$ or exercis$ or 
629 ultrasound or ultrasonograph$ or TNS or TENS or shockwave or electrotherap$or 
630 mobili$). mp. 
631 14. or/9-13
632 15. clinical trial.pt 
633 16. random$.mp. 
634 17. ((single or double) adj (blind$ or mask$)).mp. 
635 18. placebo$.mp. 
636 19. or/16-18 
637 20. 7 and 14 and 19 
638 Search strategy for EMBASE (Ovid): 
639 1. ‘shoulder pain’/exp 
640 2. ‘shoulder impingement syndrome’/exp 
641 3. ‘rotator cuff’/exp 


































































643 5. ((shoulder* OR rotator*) AND(‘bursitis’/de OR impinge* OR ‘tendonitis’/de OR 
644 ‘tendinitis’/de OR ‘tendinopathy’/ de OR pain*)) 
645 6. ‘rotator cuff’ 
646 7. #1 OR #2 OR #3 OR #4 OR #5 OR #6
647 8. ‘rehabilitation’/exp 
648 9. ‘physiotherapy’/exp 
649 10. ‘kinesiotherapy’/exp 
650 11. ‘endoscopic echography’/exp 
651 12. rehabilitat* OR physiotherapy* OR ‘physical therapy’OR ‘manual therapy’OR 
652 kinesiotherap* OR exercis* 
653 13. ‘ultrasound’/de OR ultrasonograph* OR ‘transcutaneous nerve stimulation’ OR 
654 ‘transcutaneous electricalnerve stimulation’ OR shockwave OR electrotherap*OR mobili* 
655 14. #9 OR #10 OR #11 OR #12 OR #13 OR #13
656 15. ‘randomized controlled trial’/exp 
657 16. #7 AND #14 AND #15 
658 Search strategy for CINAHL Plus (EBSCO): 
659 • S1 MH “shoulder pain” 
660 • S2 MH “shoulder impingement syndrome” 
661 • S3 MH “rotator cuff” 
662 • S4 MH bursitis+ 
663 • S5 TX (shoulder* N5 bursitis) or TX(shoulder* N5 impinge*) or TX(shoulder* N5 
664 tend?nitis) or TX(shoulder* N5 tendinopathy) or TX(shoulder* N5 pain*) 
665 • S6 TX (rotator cuff N5 bursitis) or TX(rotator cuff N5 impinge*) or TX(rotator cuff N5 
666 tend? nitis) or TX(rotator cuff N5 tendinopathy) or TX(rotator cuff N5 pain*) 
667 • S7 TX rotator cuff 
668 • S8 S1 or S2 or S3 or S4 or S5 or S6 or S7
669 • S9 MH Rehabilitation+ 
670 • S10 MH physical therapy+ 
671 • S11 MH Manual Therapy+ 
672 • S12 MH Therapeutic Exercise+ 
673 • S13 MH Ultrasonography+ 
674 • S14 TX rehabilitat* or physiotherapy* or physical therap*or manual therap* or exercise* 
675 or ultrasound or ultrasonograph* or TNS or TENS or shockwave or electrotherapy*or 
676 mobili* 
677 • S15 S10 or S11 or S12 or S13 or S14 or S15 
678 • S16 PT clinical trial 
679 • S17 TX random* 
680 • S18 TX(single blind*) or TX(single mask*) 
681 • S19 TX(double blind*) or TX(double mask*) 
682 • S20 placebo* 
683 • S21 S17 or S18 or S19 or S20 or S21 
684 • S22 S8 and S15 and S21


































































686 Email correspondence from Markus Walther clarifying if there was progression of 
687 resistance within each exercise.
688 Hi,
689 All did the same exercises.





695 Email correspondence from Kim Bennell clarifying if there was progression of 
696 resistance within each exercise.
697 Hi Peter,
698 Sounds like an interesting project.
699 No the resistance band wasn’t changed in each exercise … the program itself was progressive 
700 so the exercises were changed along the way to make them increasingly harder.
701 The exercises were checked by the physio for form particularly around correct posture. 
702 However, if the physio felt that they weren’t able to progress to the more difficult exercise or 
703 they were having pain etc, they could stay at the easier exercise level. I did manage to find 
704 the therapist handbook




709 Note: Our eligibility and exclusion criteria states progressive and resisted trials needed to state how load was 
710 applied (e.g. Theraband or weight) AND that there was progression of volume or load or both. Non-progressive 
711 or non-resisted trials could include progression of range or from static to through range. We specifically 
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